You are here: Industry Insights > COVID-19

News List

Pharma exports record 10 per cent growth in dollar terms during Q1 FY’21 expresspharma
July 20, 2020
Pharmexcil requests the government to resume Air India flights to Africa as it is the second-largest importer of Indian pharma products.
COVID-19 pushes up sales of cardiac, anti-diabetic drugs expresspharma
July 20, 2020
The sudden change in preferred therapies by masses has just taken a sharp turn from pre-COVID period when gastric, vitamin therapies were most widely used.
Indore SEZ exports log marginal decline in Apr-June amid COVID-19 pandemic expresspharma
July 20, 2020
According to an official from the Commerce Ministry, 70 per cent contribution was of medicines.
We are monitoring sale, supply of medicines for COVID-19 treatment: Haryana FDA expresspharma
July 20, 2020
Haryana Medical Services Corporation (HMSC) has procured 400 vials of remdesivir and tocilizumab from Cipla to ensure availability of key drugs.
AIIMS Ethics Committee gives nod to human clinical trial of Covaxin expresspharma
July 20, 2020
AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting phase I and II human trials of Covaxin.
Indiscriminate use led to bogus tocilizumab injections: FDCA expresspharma
July 20, 2020
A racket selling spurious tocilizumab injections which are used in the treatment of COVID-19 was recently busted following raids in Surat and Ahmedabad.
Dexamethasone’s COVID-19 benefits confirmed; spotlight on immune cells expresspharma
July 20, 2020
The full results of a large randomized clinical trial in Britain looking at the steroid dexamethasone confirmed the benefits in its use in COVID-19 patients that were hinted at in early findings issued last month.
Seven Indian pharmaceutical companies race to develop vaccine for deadly coronavirus expresspharma
July 20, 2020
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
60 Degrees announces positive results of cell culture testing of ARAKODA for Covid-19 pharmaceutical-business-review
July 17, 2020
60 Degrees Pharmaceuticals, LLC (60P) announced that initial testing in cell culture shows that ARAKODA (tafenoquine) is active against SARS-CoV-2 at clinically relevant concentrations.
Common FDA-approved drug may effectively neutralize virus that causes COVID-19 worldpharmanews
July 17, 2020
A common drug, already approved by the Food and Drug Administration (FDA), may also be a powerful tool in fighting COVID-19, according to research published this week in Antiviral Research.